Matches in Wikidata for { <http://www.wikidata.org/entity/Q80955325> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q80955325 description "artikull shkencor i botuar më 01 janar 2004" @default.
- Q80955325 description "artículu científicu espublizáu en xineru de 2004" @default.
- Q80955325 description "im Jahr 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80955325 description "scientific article published on 01 January 2004" @default.
- Q80955325 description "wetenschappelijk artikel" @default.
- Q80955325 description "наукова стаття, опублікована в січні 2004" @default.
- Q80955325 description "գիտական հոդված հրատարակված 2004 թվականի հունվարի 1-ին" @default.
- Q80955325 name "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 name "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 name "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 type Item @default.
- Q80955325 label "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 label "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 label "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 prefLabel "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 prefLabel "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 prefLabel "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 P1433 Q80955325-3FFF07B9-1E9F-4467-AC2B-148D328765FF @default.
- Q80955325 P1476 Q80955325-E85F9B7B-3914-4343-8A02-6139E56B3E1A @default.
- Q80955325 P2093 Q80955325-47565CC5-4442-464A-BE7C-562969373268 @default.
- Q80955325 P2093 Q80955325-52B8B171-5EAA-4592-B9E3-7A12E6925E04 @default.
- Q80955325 P2093 Q80955325-60C5B880-DBA2-4167-A598-770634692522 @default.
- Q80955325 P2093 Q80955325-966DCDDB-4715-4A7F-AF82-028914B7D33E @default.
- Q80955325 P2093 Q80955325-ED5DE95A-361D-42A3-BC29-F41DE13EF345 @default.
- Q80955325 P304 Q80955325-11D77974-2474-49E6-9065-CF949C7DEC99 @default.
- Q80955325 P31 Q80955325-F9CA16E3-4E52-4FE1-BADF-F4233B55BF9B @default.
- Q80955325 P433 Q80955325-BD141384-2C73-4716-9C6D-64EB680D8E2D @default.
- Q80955325 P478 Q80955325-E66BDC6D-FA58-4550-978B-A5D01B6DEB9F @default.
- Q80955325 P577 Q80955325-6A72B064-8879-4A9E-867B-4FED955FEB86 @default.
- Q80955325 P698 Q80955325-F276634D-CC54-4298-BAD1-DAF9B9049914 @default.
- Q80955325 P698 15524048 @default.
- Q80955325 P1433 Q15750084 @default.
- Q80955325 P1476 "[Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound]" @default.
- Q80955325 P2093 "Attila Bódis" @default.
- Q80955325 P2093 "Kelen Akos" @default.
- Q80955325 P2093 "Lászlo Terdy" @default.
- Q80955325 P2093 "Nóra Angyal" @default.
- Q80955325 P2093 "Zoltán Varga" @default.
- Q80955325 P304 "45-50" @default.
- Q80955325 P31 Q13442814 @default.
- Q80955325 P433 "1" @default.
- Q80955325 P478 "74" @default.
- Q80955325 P577 "2004-01-01T00:00:00Z" @default.
- Q80955325 P698 "15524048" @default.